(Q28333813)

English

Isolation of alpha-MAPI from fermentation broths during a screening program for HIV-1 protease inhibitors

scientific article (publication date: September 1991)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Isolation of alpha-MAPI from fermentation broths during a screening program for HIV-1 protease inhibitors (English)

0 references

1 reference

L-Valinamide, N(sup 2)-(((1-carboxy-2-phenylethyl)amino)carbonyl)-L-arginyl-N-(1-formyl-2-phenylethyl)-, (1(S),2(S))-

1 reference

S Stella

1

0 references

G Saddler

series ordinal

2

0 references

E Sarubbi

series ordinal

3

0 references

L Colombo

series ordinal

4

0 references

S Stefanelli

series ordinal

5

0 references

M Denaro

series ordinal

6

0 references

E Selva

series ordinal

7

0 references

language of work or name

English

0 references

publication date

September 1991

0 references

1991

1 reference

stated in

Crossref

retrieved

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/antibiotics1968/44/9/44_9_1019/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.44.1019?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

0 references

volume

44

0 references

issue

9

0 references

page(s)

1019-22

0 references

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.44.1019?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.44.1019

Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.44.1019

HIV proteinase as a target for drug action

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.44.1019

A high throughput assay for inhibitors of HIV-1 protease. Screening of microbial metabolites

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.44.1019

Low-Molecular-Weight Enzyme Inhibitors of Microbial Origin

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.44.1019

Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.44.1019

Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.44.1019

Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.44.1019

Rational design of peptide-based HIV proteinase inhibitors

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.44.1019

Identifiers

DOI

10.7164/ANTIBIOTICS.44.1019

0 references

PubMed publication ID

1938609

0 references

(Q28333813)

Isolation of alpha-MAPI from fermentation broths during a screening program for HIV-1 protease inhibitors

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)